• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Pharvaris N.V.

< Previous 1 2 3 Next >
News headline image
Pharvaris Presents Deucrictibant Clinical Data and Analysis of Endpoints for Trials of On-demand Treatment of HAE at the GA²LEN UCARE Conference 2023
December 08, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Announces Pricing of $300 Million Underwritten Offering of Ordinary Shares and Pre-funded Warrants
December 06, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks
December 06, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris to Present at the GA²LEN UCARE Conference 2023
November 30, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer
November 15, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Presents Deucrictibant Clinical Data and Real-World HAE Treatment Satisfaction Data at ACAAI 2023 Annual Scientific Meeting
November 09, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update
November 02, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris To Present at the ACAAI 2023 Annual Scientific Meeting
October 30, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris To Present at the APAAACI 2023 International Conference
October 13, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris To Present at the CIIC Fall 2023 Conference
October 04, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris To Participate in the 2023 Cantor Global Healthcare Conference
September 19, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris To Present at the 18th German Allergy Congress
September 06, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris To Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris To Present at the 2023 HAEi Regional Conference EMEA
August 23, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Reports Second Quarter 2023 Financial Results and Provides Business Update
August 07, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Presents Clinical Data at the 2023 U.S. HAEA National Summit
July 21, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Announces FDA Removal of Clinical Hold of Deucrictibant for the On-Demand Treatment of HAE
June 26, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Announces $70 Million Private Placement Financing
June 20, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Data of Deucrictibant for the On-Demand Treatment of HAE Attacks Presented at the EAACI Congress 2023
June 10, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Announces Annual Meeting of Shareholders
June 01, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Reports First Quarter 2023 Financial Results and Provides Business Update
May 08, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Deucrictibant Data Highlighted in Multiple Presentations at the C1-Inhibitor Deficiency and Angioedema Workshop
May 06, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
April 05, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks Highlighted at the 2023 HAEi Regional Conference APAC
March 18, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris to Present in Upcoming March Investor Conferences
March 02, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris to Highlight Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks at AAAAI Annual Meeting
February 24, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris to Present at SVB Securities Global Biopharma Conference
February 08, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Provides Regulatory, Clinical, and Corporate Updates
January 09, 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update
December 08, 2022
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
News headline image
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
December 08, 2022
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap